Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023

SELL
$434.7 - $599.3 $1,304 - $1,797
-3 Reduced 0.07%
4,292 $2.31 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $1,753 - $2,344
5 Added 0.12%
4,295 $2.01 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $547,330 - $642,812
1,762 Added 69.7%
4,290 $1.47 Million
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $7,074 - $8,242
22 Added 0.88%
2,528 $924,000
Q3 2022

Nov 07, 2022

BUY
$296.48 - $337.87 $889 - $1,013
3 Added 0.12%
2,506 $810,000
Q2 2022

Aug 05, 2022

BUY
$278.73 - $327.27 $15,330 - $17,999
55 Added 2.25%
2,503 $811,000
Q1 2022

May 04, 2022

SELL
$234.69 - $291.66 $49,988 - $62,123
-213 Reduced 8.0%
2,448 $701,000
Q4 2021

Jan 25, 2022

SELL
$224.85 - $279.04 $1,798 - $2,232
-8 Reduced 0.3%
2,661 $735,000
Q3 2021

Oct 27, 2021

SELL
$221.6 - $272.71 $146,699 - $180,534
-662 Reduced 19.87%
2,669 $617,000
Q1 2021

May 07, 2021

BUY
$164.32 - $212.72 $821 - $1,063
5 Added 0.15%
3,331 $622,000
Q4 2020

Feb 10, 2021

SELL
$130.46 - $172.63 $2,348 - $3,107
-18 Reduced 0.54%
3,326 $562,000
Q3 2020

Oct 29, 2020

BUY
$146.22 - $169.13 $3,216 - $3,720
22 Added 0.66%
3,344 $495,000
Q2 2020

Jul 23, 2020

BUY
$136.42 - $164.18 $7,912 - $9,522
58 Added 1.78%
3,322 $545,000
Q1 2020

May 07, 2020

BUY
$119.05 - $147.35 $9,762 - $12,082
82 Added 2.58%
3,264 $453,000
Q4 2019

Feb 04, 2020

SELL
$106.92 - $132.43 $213 - $264
-2 Reduced 0.06%
3,182 $419,000
Q2 2019

Aug 07, 2019

BUY
$110.79 - $129.32 $352,755 - $411,754
3,184 New
3,184 $353,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Trellis Advisors, LLC Portfolio

Follow Trellis Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trellis Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trellis Advisors, LLC with notifications on news.